Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | AKERO THERAPEUTICS INC AKRO | Baker Bros. Advisors LP | 2,368,378 5.100% | 2,368,378 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | VERSARTIS INC ARAV | Baker Bros. Advisors LP | 4,586,404 7.500% | 3,160,094 (+221.56%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | SURROZEN INC SRZN | Baker Bros. Advisors LP | 55,556 2.300% | -166,666 (-75.00%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | HOOKIPA PHARMA INC HOOK | Baker Bros. Advisors LP | 347,554 6.600% | 347,554 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | OPTHEA LTD SPONSORED ADR OPTEY | Baker Bros. Advisors LP | 31,627,844 6.800% | 5,200,323 (+19.68%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 3,618 9.990% | 3,618 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | 2SEVENTY BIO INC TSVT | Baker Bros. Advisors LP | 2,062,744 5.400% | 2,062,744 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | VERASTEM, INC. VSTM | Baker Bros. Advisors LP | 2,249,075 13.500% | 458,106 (+25.58%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Baker Bros. Advisors LP | 19,184,794 9.950% | 720,050 (+3.90%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ZYMEWORKS INC ZYME | Baker Bros. Advisors LP | 3,814,196 5.900% | 3,814,196 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | CERUS CORP CERS | Baker Bros. Advisors LP | 16,087,422 9.100% | 2,354,363 (+17.14%) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | MERUS N V COM MRUS | Baker Bros. Advisors LP | 0 0.000% | -2,037,469 (Position Closed) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Baker Bros. Advisors LP | 69,359,359 9.990% | 4,441,758 (+6.84%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ACHILLES THERAPEUTICS PLC ACHL | Baker Bros. Advisors LP | 4,207,733 9.900% | 168,253 (+4.17%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | Baker Bros. Advisors LP | 255,361 9.900% | 53,582 (+26.55%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | Baker Bros. Advisors LP | 4,954,855 8.700% | 413,251 (+9.10%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | Baker Bros. Advisors LP | 56,482 8.000% | 4,145 (+7.92%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | BIOMEA FUSION INC BMEA | Baker Bros. Advisors LP | 2,104,559 7.200% | 2,104,559 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | CABALETTA BIO INC CABA | Baker Bros. Advisors LP | 1,344,000 5.200% | 1,344,000 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT | Baker Bros. Advisors LP | 2,492,118 7.000% | 2,492,118 (New Position) | Filing History |